These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14612100)

  • 1. Effect of grapefruit juice on serum concentration of cyclosporine in Iranian renal transplant patients.
    Mehrsai AR; Pourmand G; Mansour D; Zand S; Rezaali A
    Transplant Proc; 2003 Nov; 35(7):2739-41. PubMed ID: 14612100
    [No Abstract]   [Full Text] [Related]  

  • 2. Intake of grapefruit juice alters the metabolic pattern of cyclosporin A in renal transplant recipients.
    Hermann M; Asberg A; Reubsaet JL; Sather S; Berg KJ; Christensen H
    Int J Clin Pharmacol Ther; 2002 Oct; 40(10):451-6. PubMed ID: 12395977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between cyclosporine and grapefruit juice requires long-term ingestion in stable renal transplant recipients.
    Brunner LJ; Munar MY; Vallian J; Wolfson M; Stennett DJ; Meyer MM; Bennett WM
    Pharmacotherapy; 1998; 18(1):23-9. PubMed ID: 9469677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of orange and tangerine juice on cyclosporine levels in renal transplant recipients.
    Sorkhi H; Oliaei F; Moghadamnia AA; Pouramin M; Firoozjahi AR
    Transplant Proc; 2007 May; 39(4):1228-30. PubMed ID: 17524940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of grapefruit juice on Sandimmun Neoral absorption among stable renal allograft recipients.
    Bistrup C; Nielsen FT; Jeppesen UE; Dieperink H
    Nephrol Dial Transplant; 2001 Feb; 16(2):373-7. PubMed ID: 11158415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tangerine juice on cyclosporine levels in renal transplant children.
    Sorkhi H; Moghadamnia AA; Oaliaee F; Pouramir M; Firoozjahi AR; Pasha AA; Goodarzi MR
    Pediatr Nephrol; 2008 Mar; 23(3):499-501. PubMed ID: 18030500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma endothelin in cyclosporine A-treated renal transplant patients.
    Grekas D; Bamichas G; Karamouzis M; Bacharaki D; Savidis N; Tourkantonis A
    Transplant Proc; 1999 May; 31(3):1703-5. PubMed ID: 10331044
    [No Abstract]   [Full Text] [Related]  

  • 8. A trial of oral magnesium supplementation in renal transplant recipients receiving cyclosporine.
    Nguyen T; Steiner RW
    Transplant Proc; 1998 Dec; 30(8):4317-9. PubMed ID: 9865371
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum cyclosporine level and orange juice in pediatric renal-transplanted patients.
    Sorkhi H; Moghadamnia AA; Oaliaee F; PourAmir M; Firoozjahi AR; Pasha AA; Goodarzi MR
    Pediatr Transplant; 2009 Jun; 13(4):411-3. PubMed ID: 18547379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nicardipine on blood cyclosporine levels in renal transplant patients.
    Guan D; Wang R; Lu J; Wang M; Xu C
    Transplant Proc; 1996 Jun; 28(3):1311-2. PubMed ID: 8658673
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of chronic ingestion of grapefruit juice on steady-state blood concentrations of cyclosporine A in renal transplant patients with stable graft function.
    Proppe DG; Hoch OD; McLean AJ; Visser KE
    Br J Clin Pharmacol; 1995 Mar; 39(3):337-8. PubMed ID: 7619679
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimal blood concentration of cyclosporine among Iranian kidney transplant recipients.
    Rostami Z; Einollahi B; Morshedi J; Teimoori M
    Iran J Kidney Dis; 2012 Sep; 6(5):373-9. PubMed ID: 22976264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sandimmun and Neoral treatment: pharmacokinetics and kidney function in paediatric and adolescent renal transplant.
    De Palma MT; Giordano M; Colella V; Palumbo F; De Nicolo VE; Caringella DA
    Transplant Proc; 1998 Aug; 30(5):1677. PubMed ID: 9723239
    [No Abstract]   [Full Text] [Related]  

  • 14. Study of the cyclosporine concentration at 2 hours in stable renal transplant patients and relation to body mass index.
    Hortal L; Fernández A; Losada A; Lorenzo M; Baamonde E; Plaza C; Gallego R; Vega N; Palop L
    Transplant Proc; 2001; 33(7-8):3110-1. PubMed ID: 11750337
    [No Abstract]   [Full Text] [Related]  

  • 15. Convenience of level of cyclosporine-Neoral at time 3 to determine the area under curve in renal transplant.
    Rial MC; Frias S; Argento J; Tessler J; Casadei D
    Transplant Proc; 1997; 29(1-2):292-3. PubMed ID: 9123001
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic study of twice vs thrice daily dosing of Sandimmun Neoral in pediatric renal transplant patients.
    Papachristou F; Gakis D; Sotiriou I; Liatsis I; Takoudas D; Antoniadis A
    Transplant Proc; 1998 Aug; 30(5):1988-90. PubMed ID: 9723363
    [No Abstract]   [Full Text] [Related]  

  • 17. Ten years after: long-term effects of cyclosporine-based immunosuppression on renal allograft recipients.
    Kondo T; Kinukawa T; Takeuchi N; Hattori R; Ono Y; Matsuura O; Fujita T; Ohshima S
    Transplant Proc; 1998 Nov; 30(7):3530-2. PubMed ID: 9838546
    [No Abstract]   [Full Text] [Related]  

  • 18. A retrospective analysis of Neoral C2 monitoring in Chinese renal transplantation recipients.
    Tan J; Tang X
    Transplant Proc; 2003 Feb; 35(1):232-3. PubMed ID: 12591377
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of lymphocyte cyclosporine levels in transplant patients.
    Masri MA; Barbari A; Stephan A; Rizk S; Kilany H; Kamel G
    Transplant Proc; 1998 Nov; 30(7):3561-2. PubMed ID: 9838559
    [No Abstract]   [Full Text] [Related]  

  • 20. Conversion from Sandimmune to Neoral in renal transplant recipients: two-year experience.
    Wilczek HE; Akesson P; Warholm C
    Transplant Proc; 1998 Aug; 30(5):1753-5. PubMed ID: 9723267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.